Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 65

Sort by

Sort Order Select

Journal Articles

Intravascular large B-cell lymphoma presenting with acute encephalopathy

Eric McGinnis, Pedro Farinha

Blood (2020) 135 (21): 1916.

https://doi.org/10.1182/blood.2020005457

Published: 2020

Journal Articles

APR-246 Combined with Azacitidine (AZA) in TP53 Mutated Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML). a Phase 2 Study By the Groupe Francophone Des Myélodysplasies (GFM)

Blood (2019) 134 (Supplement_1): 677.

https://doi.org/10.1182/blood-2019-125579

Published: 2019

Journal Articles

The Geriatric Syndrome of Sarcopenia Impacts Allogeneic Hematopoietic Cell Transplantation Outcomes in Combination with Multi-Morbidity and Functional Impairment

Richard J Lin, MD PhD, Laure Michaud, MD, Stephanie M Lobaugh, MS, Reiko Nakajima, MD, Theresa A Elko, MS, Josel D Ruiz, MPH, Craig S. Sauter, MD, Parastoo B. Dahi, MD, Molly A. Maloy, MS, Miguel-Angel Perales, MD, Soo Jung Kim, NP, Beatriz Korc-Grodzicki, MD PhD, Sean M. Devlin, PhD, Michael Scordo, MD, Heiko Schoder, MD, Sergio A Giralt, MD, Paul A. Hamlin, MD

Blood (2019) 134 (Supplement_1): 4508.

https://doi.org/10.1182/blood-2019-125141

Published: 2019

Journal Articles

Analysis of the Eligibility of Patients with Sickle Cell Disease for Palliative Care

Pedro de Oliveira Toro da Silva, Cristina Bueno Terzi, MD PhD, Antonio Luis Eiras Falcão, MD PhD, Sara T Olalla Saad, PhD, Fernando Ferreira Costa, MD PhD, Paula De Melo Campos, MD

Blood (2019) 134 (Supplement_1): 4681.

https://doi.org/10.1182/blood-2019-128884

Published: 2019

Journal Articles

Sinusoidal Obstructive Syndrome Among Pediatric and Adolescent and Young Adult Patients: Analysis of Pediatric EBMT Diagnostic and Severity Criteria at MD Anderson

Francesco Tambaro, MD PhD, Dristhi Ragoonanan, Sajad Khazal, MD, Demetrios Petropoulos, MD, Priti Tewari, MD, Partow Kebriaei, MD, William G. Wierda, MD PhD, Mira A. Kohorst, MD, Kris Michael Mahadeo, MD

Blood (2019) 134 (Supplement_1): 4495.

https://doi.org/10.1182/blood-2019-132085

Published: 2019

Journal Articles

Neurological Adverse Events Following CAR-T Cell Therapy: A Real-World Analysis of Adult Patients Treated with Axicabtagene Ciloleucel or Tisagenlecleucel

Ajeet Gajra, MD FACP, Marjorie E Zettler, PhD MPH, Eli G Phillips Jr., PharmD, JD, Andrew J Klink, PhD MPH, Jonathan K. Kish, PhD MPH, Sonam Mehta, Bruce Feinberg, DO

Blood (2019) 134 (Supplement_1): 1952.

https://doi.org/10.1182/blood-2019-129593

Published: 2019

Journal Articles

Immunologic and Brain Bases of Neurotoxicity Associated with CAR T-Cell Therapy

Deepa Bhojwani, MD, Bradley Peterson, MD, Agne Taraseviciute, MD PhD, Michael A. Pulsipher, MD, Alan S. Wayne, MD, Michael Sheard, PhD, Courtney Allem, Joey Trampush, PhD, Ravi Bansal, PhD

Blood (2019) 134 (Supplement_1): 1946.

https://doi.org/10.1182/blood-2019-127533

Published: 2019

Journal Articles

An Individualized Risk Mitigation Approach for Safety: Experience from the Mosunetuzumab (CD20/CD3 Bispecific Antibody) Development Program in Relation to Neurotoxicity Risk

Catherine Diefenbach, MD, Sarit Assouline, MD, Francesc Bosch, MD PhD, Chan Y. Cheah, Won Seog Kim, MD PhD, Matthew J Matasar, MD, Carlos Panizo, MD PhD, Dok Hyun Yoon, MD PhD, Brendan Bender, PhD, Genevive Hernandez, PhD, Chi-Chung Li, PhD, Bruce McCall, MD, Carol O'Hear, MD PhD, Michael C Wei, MD PhD, Shen Yin, PhD, Kasra Yousefi, MSc, Antonia Kwan, MD PhD MRCPCH, Loretta J. Nastoupil, MD MSc

Blood (2019) 134 (Supplement_1): 4728.

https://doi.org/10.1182/blood-2019-123757

Published: 2019

Journal Articles

A U.S. Food and Drug Administration Age Based Pooled Analysis of Cytokine Release Syndrome and Neurotoxicity in Subjects with Relapsed/Refractory Lymphoma Treated with Chimeric Antigen Receptor (CAR) T Cell Therapy

Poornima Sharma, MD, Harpreet Singh, MD, Najat Bouchkouj, MD, Aviva C. Krauss, MD, Bindu George, MD

Blood (2018) 132 (Supplement 1): 4201.

https://doi.org/10.1182/blood-2018-99-115188

Published: 2018

Journal Articles

Management of Diffuse Large B Cell Lymphoma in the Oldest Old—Insight into the Management Decision Process: A Canadian Perspective

Annie Lacerte, MD PhD, Marie-Pier Bleau, MD, Jean-Francois Castilloux, MD, Flavia De-angelis, MD, Pierre Desjardins, MD, Michel Pavic, MD, Tamas Fulop, MD PhD

Blood (2018) 132 (Supplement 1): 4213.

https://doi.org/10.1182/blood-2018-99-117640

Published: 2018

Journal Articles

Burden and Impact of Geriatric Syndromes Associated with Allogeneic Hematopoietic Cell Transplantation in Older Adults

Richard J Lin, MD PhD, Theresa A Elko, MS, Patrick Hilden, MS, Parastoo B. Dahi, MD, Ann A. Jakubowski, MD PhD, Miguel-Angel Perales, MD, Juliet Barker, MBBS, H.R. Castro-Malaspina, MD, Brian C. Shaffer, MD, Armin Shahrokni, MD, Roni Tamari, MD, Esperanza B. Papadopoulos, MD, Craig S. Sauter, MD, Molly Maloy, MS, Beatriz Korc-Grodzicki, MD PhD, Sergio Giralt, MD

Blood (2018) 132 (Supplement 1): 3370.

https://doi.org/10.1182/blood-2018-99-113876

Published: 2018

Journal Articles

Phase II Trial of Bortezomib-Based Induction, Autologous Stem Cell Transplantation, Bortezomib-Based Consolidation, and Bortezomib Maintenance in Newly Diagnosed Multiple Myeloma in Japan

Blood (2018) 132 (Supplement 1): 3305.

https://doi.org/10.1182/blood-2018-99-113816

Published: 2018

Journal Articles

A Rare Case of Delirium: Acquired Thrombotic Thrombocytopenic Purpura in an HIV Patient

Kinjal Solanki, MD BA, Syed Haris A Pir, MD, Constantine Khoury, Jose F. Cervantes, MD

Blood (2018) 132 (Supplement 1): 5007.

https://doi.org/10.1182/blood-2018-99-120231

Published: 2018

Journal Articles

Chemosensitive Disease Better Predicts Outcome Than Age Following Autologous Heamatopoietic Stem Cell Transplantation in Elderly Patients with Multiple Myeloma

Christopher Lemieux, MD, Robert Delage, MD, Guy Cantin, MD, Frederic Barabe, MD, Vincent Laroche, MD, Rémy Angers, BSc, Genevieve Gallagher, MD

Blood (2017) 130 (Supplement 1): 5530.

https://doi.org/10.1182/blood.V130.Suppl_1.5530.5530

Published: 2017

Journal Articles

Toxicity and Outcomes of Autologous Stem Cell Transplant in Multiple Myeloma Patients with Renal Insufficiency: An Institutional Comparison between Two Eras

Amanda Li, MD BSc, Eshetu G Atenafu, M.Sc., P.Stat, Rosanne St. Bernard, MD MSc, Esther Masih-Khan, PhD, Donna Reece, MD FRCP(C), Norman Anthony Franke, MD, Rodger Tiedemann, MBChB, PhD, Anca Prica, MD FRCP(C), Suzanne Trudel, MD FRCP(C), Vishal Kukreti, MD FRCP(C), Christine I Chen, MD FRCP(C)

Blood (2017) 130 (Supplement 1): 4537.

https://doi.org/10.1182/blood.V130.Suppl_1.4537.4537

Published: 2017

Journal Articles

Phase I/II Study of Pembrolizumab for Progressive Diffuse Large B Cell Lymphoma after Anti-CD19 Directed Chimeric Antigen Receptor Modified T Cell Therapy

Elise A. Chong, MD, J. Joseph Melenhorst, PhD, Jakub Svoboda, MD, Sunita Dwivedy Nasta, MD, Daniel J. Landsburg, MD, Anthony R. Mato, MD, Lifeng Tian, PhD, Harit Parakandi, Simon F Lacey, PhD BS, Carl H June, MD, Stephen J. Schuster, MD

Blood (2017) 130 (Supplement 1): 4121.

https://doi.org/10.1182/blood.V130.Suppl_1.4121.4121

Published: 2017

Journal Articles

Endothelial Activation and Blood-Brain Barrier Disruption in Neurotoxicity after CD19 CAR-T Cell Immunotherapy

Cameron J. Turtle, MBBS, PhD, Kevin A. Hay, MD FRCPC, MSc, Laila-Aicha Hanafi, PhD, Juliane Gust, MDPhD, W. Conrad Liles, MDPhD, José A. López, MD, Junmei Chen, PhD, Dominic W. Chung, PhD, Mark M Wurfel, MDPhD, Susanna Harju-Baker, PhD, Hasan Ozpolat, MD, Daniel Li, PhD, David Myerson, MDPhD, Luis F. Gonzalez-Cuyar, MD, Cecilia Yeung, MD, Kathleen R. Fink, MD, Stanley R. Riddell, MD, David G. Maloney, MD PhD

Blood (2017) 130 (Supplement 1): 805.

https://doi.org/10.1182/blood.V130.Suppl_1.805.805

Published: 2017

Journal Articles

Hematopoietic Stem Cell Transplantation at Home

Anthony D. Sung, MD, Krista R. Nichols, RN, MSN, AOCNS, Julia A. Messina, MD, Kristi Romero, BA, Tara Dalton, MBS, Amy Bush, BA, Megan Covington, BS, Rebecca Shelby, PhD, Jennifer Frith, RN, MSN, OCN, Cristina J. Gasparetto, MD, Mitchell E. Horwitz, MD, Gwynn D. Long, MD, Richard Lopez, MD, David A. Rizzieri, MD, Stefanie Sarantopoulos, MD PhD, Keith M. Sullivan, MD, Nelson J. Chao, MDM.B.A

Blood (2017) 130 (Supplement 1): 745.

https://doi.org/10.1182/blood.V130.Suppl_1.745.745

Published: 2017

Journal Articles

Data of Real-Life Anticoagulant Treatment in Patients Diagnosed with Nonvalvular Atrial Fibrillation and Secondary Prevention of Venous Thromboembolic Disease with Edoxaban: Experience in Our Center

Maria Almudena Garcia Ruiz, Marta Rivas Luque, Pablo Romero Garcia, MDCINE Resident, Manuel Jurado, MD PhD

Blood (2017) 130 (Supplement 1): 4920.

https://doi.org/10.1182/blood.V130.Suppl_1.4920.4920

Published: 2017

Journal Articles

Treatment with Chimeric Antigen Receptor Modified T Cells Directed Against CD19 (CTL019) Results in Durable Remissions in Patients with Relapsed or Refractory Diffuse Large B Cell Lymphomas of Germinal Center and Non-Germinal Center Origin, "Double Hit" Diffuse Large B Cell Lymphomas, and Transformed Follicular to Diffuse Large B Cell Lymphomas

Stephen J. Schuster, MD, Jakub Svoboda, MD, Sunita Dwivedy Nasta, MD, Elise A. Chong, MD, Nicole Winchell, Daniel J. Landsburg, MD, David L. Porter, MD, Anthony R. Mato, MD, Honore T Strauser, April M. Schrank-Hacker, Mariusz A Wasik, MD, Simon Francis Lacey, PhD BS, Jan Joseph Melenhorst, PhD, Anne Chew, PhD, Jens Hasskarl, MD PhD, Katherine T. Marcucci, PhD, Bruce L Levine, PhD, Carl H June, MD

Blood (2016) 128 (22): 3026.

https://doi.org/10.1182/blood.V128.22.3026.3026

Published: 2016

NARROW

Intravascular large B-cell lymphoma presenting with acute encephalopathy

APR-246 Combined with Azacitidine (AZA) in TP53 Mutated Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML). a Phase 2 Study By the Groupe Francophone Des Myélodysplasies (GFM)

The Geriatric Syndrome of Sarcopenia Impacts Allogeneic Hematopoietic Cell Transplantation Outcomes in Combination with Multi-Morbidity and Functional Impairment

Analysis of the Eligibility of Patients with Sickle Cell Disease for Palliative Care

Sinusoidal Obstructive Syndrome Among Pediatric and Adolescent and Young Adult Patients: Analysis of Pediatric EBMT Diagnostic and Severity Criteria at MD Anderson

Neurological Adverse Events Following CAR-T Cell Therapy: A Real-World Analysis of Adult Patients Treated with Axicabtagene Ciloleucel or Tisagenlecleucel

Immunologic and Brain Bases of Neurotoxicity Associated with CAR T-Cell Therapy

An Individualized Risk Mitigation Approach for Safety: Experience from the Mosunetuzumab (CD20/CD3 Bispecific Antibody) Development Program in Relation to Neurotoxicity Risk

A U.S. Food and Drug Administration Age Based Pooled Analysis of Cytokine Release Syndrome and Neurotoxicity in Subjects with Relapsed/Refractory Lymphoma Treated with Chimeric Antigen Receptor (CAR) T Cell Therapy

Management of Diffuse Large B Cell Lymphoma in the Oldest Old—Insight into the Management Decision Process: A Canadian Perspective

Burden and Impact of Geriatric Syndromes Associated with Allogeneic Hematopoietic Cell Transplantation in Older Adults

Phase II Trial of Bortezomib-Based Induction, Autologous Stem Cell Transplantation, Bortezomib-Based Consolidation, and Bortezomib Maintenance in Newly Diagnosed Multiple Myeloma in Japan

A Rare Case of Delirium: Acquired Thrombotic Thrombocytopenic Purpura in an HIV Patient

Chemosensitive Disease Better Predicts Outcome Than Age Following Autologous Heamatopoietic Stem Cell Transplantation in Elderly Patients with Multiple Myeloma

Toxicity and Outcomes of Autologous Stem Cell Transplant in Multiple Myeloma Patients with Renal Insufficiency: An Institutional Comparison between Two Eras

Phase I/II Study of Pembrolizumab for Progressive Diffuse Large B Cell Lymphoma after Anti-CD19 Directed Chimeric Antigen Receptor Modified T Cell Therapy

Endothelial Activation and Blood-Brain Barrier Disruption in Neurotoxicity after CD19 CAR-T Cell Immunotherapy

Hematopoietic Stem Cell Transplantation at Home

Data of Real-Life Anticoagulant Treatment in Patients Diagnosed with Nonvalvular Atrial Fibrillation and Secondary Prevention of Venous Thromboembolic Disease with Edoxaban: Experience in Our Center

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only